Rich Azueta has over 24 years of experience in clinical research and the pharmaceutical industry. Rich started working as a clinical research coordinator at the Bronx VA/Mt. Sinai Medical Center first in psychiatry (including imaging) and then in Ophthalmology. He moved onto Forest Laboratories as a Clinical Research Associate where he monitored Phase 1 and Phase 2 studies. Following that Rich joined Pfizer as a Clinical Study Manager of global Phase 3 and Phase 4 studies. Rich made the switch to Quality Assurance by moving to Pfizer’s corporate audit group which had oversight of global GCP and PV targets. Rich continued as a PV auditor at Schering-Plough before moving to Novartis Oncology as a Quality Manager. He has progressed into leadership roles at Novartis both as head of Novartis Oncology’s QA organization to his current role as Head of GxP Audit, Novartis Group Compliance and Audit where he is responsible for internal GxP audits across the Novartis Group network. Rich did his undergraduate work in Psychology at Hunter College. He holds an MS in Quality Assurance and Regulatory Affairs from Temple University and an MBA from Baruch College/Mt. Sinai School of Medicine. Rich is a Certified Quality Auditor by the American Society for Quality and a Registered Quality Assurance Professional (GCP) by the Society of Quality Assurance.